Clinical Trial Update: Measuring of the Duration of Action of Different Doses of Rocuronium-induced Neuromuscular Block in Infants During Surgical Treatment of Craniosynostosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating how long Rocuronium-induced neuromuscular blockade lasts in infants during craniosynostosis surgery across different …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniosynostosis

Drugs mentioned

• Rocuronium (rocuronium bromide)

Snippet

Sponsor: Tamas Vegh, MD | Conditions: Neuromuscular Blocking Agents, Residual Neuromuscular Block | Phase 4 | Status: ENROLLING_BY_INVITATION